DNase I hypersensitive site maps to the HBV enhancer

Area of Science:

• Molecular Biology
• Virology
• Epigenetics

Background:

• Hepatitis B virus (HBV) infection remains a significant global health concern.
• Understanding the regulation of HBV gene expression is critical for developing antiviral strategies.
• Transgenic mouse models offer valuable insights into viral gene regulation in vivo.

Purpose of the Study:

• To investigate the epigenetic mechanisms regulating Hepatitis B virus (HBV) gene expression in transgenic mice.
• To examine the correlation between DNA methylation, chromatin structure, and HBV transcription.
• To identify specific regulatory regions involved in HBV gene expression.

Main Methods:

• Generation of two lines of HBV transgenic mice (G7 and G26).
• Analysis of DNA methylation status at HpaII and HhaI sites within HBV sequences.
• Chromatin structure analysis using DNase I digestion and indirect end-labeling.
• Correlation of epigenetic modifications with HBV gene expression in liver and kidney tissues.

Main Results:

• Hypomethylation of specific DNA sites strongly correlated with HBV gene expression.
• A major DNase I hypersensitive site (HS) was identified in the HBV enhancer region in expressing tissues.
• This enhancer HS was necessary but not sufficient for HBV expression.
• An additional HS was found in the core promoter of the G7 transgene, but not G26.

Conclusions:

• Epigenetic modifications, including DNA hypomethylation and altered chromatin structure, play a significant role in regulating HBV gene expression.
• The HBV enhancer region, indicated by a DNase I hypersensitive site, is a key regulatory element involved in viral transcription.
• These findings highlight the complex interplay of epigenetic factors in controlling HBV gene expression in vivo.